U.S. Medical Equipment Stock News

Recent performance snapshot and trigger context Otter Tail (OTTR) has attracted fresh attention after recent share price moves, with the stock finishing the latest session at US$87.35 and showing mixed returns over the past month and past 3 months. Over the past month, Otter Tail is down about 1%, while the past 3 months show a gain of roughly 1.4%. Year to date, the stock is up around 7.2%, and the 1 year total return stands near 17.7%. That performance sits against a backdrop of annual...

What Recent Performance Says About Taylor Morrison Home (TMHC) Taylor Morrison Home (TMHC) has drawn investor attention after a recent pullback, with the stock down about 8% over the past month and 13% over the past 3 months, while longer term returns remain positive. See our latest analysis for Taylor Morrison Home. While the share price has eased recently, with a 30 day share price return of down 8.3% and 90 day share price return of down 13.3%, the 1 year total shareholder return of 2.8%...

Why Ingram Micro Holding (INGM) is back on investors’ radar Ingram Micro Holding (INGM) has drawn fresh attention after being selected as one of only two global distributors for Hewlett Packard Enterprise. The company will gain full access to HPE’s networking, cloud, and AI portfolio. This appointment arrives after a period in which Ingram Micro’s sales have been largely flat and earnings per share have contracted by 8.6% annually over the past three years. Free cash flow margins near 0.2%...

Synopsys (SNPS) is back in focus after American Megatrends International, Arm and Synopsys jointly unveiled an accelerated “Shift Left” initiative that moves key firmware verification into earlier RTL validation for custom silicon projects. See our latest analysis for Synopsys. That Shift Left announcement comes at a time when momentum in the stock has been firm, with a 90 day share price return of 19.06% and a 5 year total shareholder return of 106.31%, indicating solid long term compounding...

Bicara Therapeutics (BCAX) drew fresh investor focus after presenting three year follow up data for ficerafusp alfa plus pembrolizumab in first line HPV negative head and neck cancer, covering roughly 90 patients across three dose cohorts. See our latest analysis for Bicara Therapeutics. The latest ficerafusp alfa data helped extend Bicara's recent momentum, with a 1-day share price return of 4.03% and a 7-day share price return of 12.39%. The 1-year total shareholder return of 133.87% sits...

In the recent past, Paycom Software reported Q1 2026 results with revenue and earnings per share coming in slightly ahead of analyst expectations, while issuing relatively cautious full-year revenue guidance versus other HR software providers. Despite slower growth and the weakest guidance among its peers, Paycom’s continued use of share buybacks funded partly by its credit facility highlights management’s conviction in the company’s underlying fundamentals and valuation. We’ll now explore...

Bel Fuse stock snapshot and recent performance Bel Fuse (BELF.A) has attracted investor attention after a strong run, with the stock up 6.9% over the past day and 7.6% over the past week, despite a flat month. Over the past 3 months, the stock has gained 17.0%, contributing to a year to date return of 65.0% and a 1 year total return of 292.3%. This places the recent moves in a longer performance context. See our latest analysis for Bel Fuse. At a share price of $252.34, Bel Fuse has seen...

Recent performance snapshot IAC (IAC) has drawn fresh attention after recent trading, with the stock last closing at US$42.03. Short term returns have been mixed, including a 2.1% gain over the past day and a 3.2% move over the past week. Over longer stretches, performance has varied. The stock is down 5.5% over the past month but up 17.5% over the past 3 months and 15.8% over the past year on a total return basis. See our latest analysis for IAC. For context, IAC’s recent 1-day and 7-day...

Recent share performance and what it signals for investors Huntsman (HUN) has drawn attention after a period of solid share performance, with the stock up 0.9% over the past day, 5.1% over the past week, and 6.5% over the past month. Over the past 3 months, the stock is up 11.6%, while the 1 year total return stands at 35.2%. Year to date, Huntsman is up 42.4%, which places recent trading action front and center for investors reviewing materials sector exposure. See our latest analysis for...

Earnings driven move after guidance hike Evolv Technologies Holdings (EVLV) recently reported first quarter 2026 results, lifting full year revenue guidance and outlining an expectation for positive adjusted EBITDA, a combination that appears central to the latest stock reaction. See our latest analysis for Evolv Technologies Holdings. The Q1 guidance hike and customer wins appear to sit against mixed momentum, with the share price up 23.56% over 90 days but down 6.87% year to date. The 1...

Ventas stock in focus Ventas (VTR) is back on investor radar after recent trading put fresh attention on its role as a large healthcare focused real estate investment trust, with about 1,400 properties across North America and the United Kingdom. See our latest analysis for Ventas. Recent trading has kept Ventas in an uptrend, with a 30 day share price return of 5.45% and a 1 year total shareholder return of 41.30%, suggesting that positive momentum has been building over time. If this...

In May 2026, Expedia Group released its Unpack ’26 Summer report, revealing a shift toward domestic, value-focused, and event-driven travel, including trends like hotel hopping, road trips, bleisure trips, and screen-inspired “set-jetting,” alongside diverging patterns linked to major international sports events. The report also introduced Expedia’s Smart Travel Health Check, highlighting how the company is tying demand insights to sustainability and destination stewardship, which could...

Earlier in May 2026, Willis Towers Watson declared a quarterly dividend of US$0.96 per share and introduced a Carbon Capture and Storage insurance suite spanning CO₂ capture, transport, storage, and related project risks. At the same time, the company faced growing legal and regulatory attention, including a lawsuit over alleged broker poaching and a shareholder-focused investigation tied to slower Q1 2026 organic revenue growth and margin pressure. Against this backdrop of new CCS insurance...

Hasbro (HAS) just posted first quarter results that topped expectations, powered by its Wizards of the Coast division and Magic: The Gathering, but kept full year guidance steady while flagging revenue timing issues from a recent cyberattack. See our latest analysis for Hasbro. The share price is down 2.2% over the past day and 11.7% over the past 90 days. However, the 1 year total shareholder return of 37.2% and 3 year total shareholder return of 65.3% indicate that longer term momentum has...

Applied Materials (NasdaqGS:AMAT) is partnering with Meta, Broadcom, GlobalFoundries, and Synopsys to create a $125 million semiconductor research hub at UCLA. The new center will focus on next generation chip manufacturing and AI related technologies, connecting industry, design, and academic research. The collaboration is intended to support long term research infrastructure, workforce development, and US semiconductor supply chain resilience. For investors watching NasdaqGS:AMAT, this...

Madrigal Pharmaceuticals recently announced that multiple new data sets from its Rezdiffra development and real‑world evidence programs were presented at the EASL Congress 2026, covering cardiometabolic risk, non‑invasive risk stratification in compensated cirrhosis, and early real‑world effectiveness in routine practice. The breadth of these presentations, including biomarker‑based prediction of fibrosis improvement and machine‑learning models for staging MASH, reinforces how central...

Dutch Bros (BROS) is back on investor radar after first quarter results beat expectations, analysts highlighted its brand strength and menu expansion, and new shops rolled out in key markets like Chicago and Bloomington Normal. See our latest analysis for Dutch Bros. Despite upbeat commentary around new store openings and menu additions, Dutch Bros’ share price is down 16.15% year to date and 9.26% over the past month. The three year total shareholder return of 86.01% points to longer term...

Recent performance snapshot Hilton Worldwide Holdings (HLT) has been on many investors’ screens after a period of mixed short term returns, with the stock down about 4% over the past month but up roughly 3% over the past 3 months. See our latest analysis for Hilton Worldwide Holdings. At a share price of US$321.08, Hilton’s recent 30-day share price decline of about 4% contrasts with a 1-year total shareholder return of 31.45%, indicating that longer term performance has differed from the...

In May 2026, Raymond James Financial filed a US$400.30 million shelf registration for 2,600,000 common shares tied to an ESOP-related offering and, earlier that month, its board declared a US$0.54 quarterly dividend payable on July 15, 2026 to shareholders of record on July 1, 2026. Alongside these capital actions, the firm reported record client assets under administration of US$1.87 trillion driven by higher markets and net inflows, underscoring the scale of its fee-based advisory...

Over the last 7 days, the United States market has risen by 1.1%, contributing to an impressive 29% climb over the past year, with earnings forecasted to grow by 17% annually. In such a robust environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors seeking to capitalize on market growth while considering intrinsic value.

Over the last 7 days, the United States market has risen by 1.1%, contributing to a remarkable 29% increase over the past year, with earnings anticipated to grow by 17% annually in the coming years. In this thriving environment, identifying growth companies with high insider ownership can be crucial as they often demonstrate strong alignment between management and shareholder interests while potentially capitalizing on robust revenue growth opportunities.

The market has climbed 1.1% in the last 7 days and is up 29% over the last 12 months, with earnings expected to grow by 17% per annum over the next few years. While 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still offer significant opportunities when built on solid financials. We've identified three penny stocks that combine balance sheet strength with potential for outsized gains, allowing investors to explore hidden value in quality...

The United States market has shown a robust performance, with a 1.1% increase over the last week and an impressive 29% rise over the past year, while earnings are projected to grow by 17% annually. In such a dynamic environment, identifying undiscovered gems involves seeking stocks that not only align with these growth trends but also offer unique value propositions and potential for long-term appreciation.

The United States market has shown robust performance, with a 1.1% increase over the last week and a remarkable 29% rise over the past year. In this dynamic environment, dividend stocks can offer a compelling opportunity for investors seeking steady income and potential growth, especially when yields are as attractive as up to 5.7%.